A Randomised, Double-Blind, Placebo-Controlled, Parallel Dose Comparison Study Evaluating Safety and Efficacy of SVT-6A4710 in Adults with active Rheumatoid Arthritis Despite Methotrexate Therapy.
Latest Information Update: 06 Dec 2021
At a glance
- Drugs SVT-6A4710 (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Servatus Biopharmaceuticals
- 06 Dec 2021 New trial record